# Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

> **NCT06069310** · — · ACTIVE_NOT_RECRUITING · sponsor: **National and Kapodistrian University of Athens** · enrollment: 40 (actual)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps
- Severe Eosinophilic Asthma
- Chronic Rhinosinusitis Without Nasal Polyps

## Interventions

- **DRUG:** Mepolizumab 100 MG

## Key facts

- **NCT ID:** NCT06069310
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-03-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069310, "Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06069310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*